← Leaderboards
Kenneth P Olive
Columbia University Health Sciences
$11,212,298
Attributed
$14,008,172
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,008,172 · 10
By mechanism
R01$7,041,538 · 3
U01$3,892,796 · 1
P30$2,156,169 · 3
S10$393,698 · 1
R21$378,771 · 1
F32$145,200 · 1
Top collaborators
- Gulam Abbas Manji7 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Aniruddha Das$5,526,230
- Timothy Cragin Wang$52,188,834
- Hui Zhang$4,266,519
- Chuchun Liz Chang$2,784,551
- Richard S Mann$30,290,569
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMouse ModelCellsMalignant NeoplasmsPancreatic NeoplasmIn VivoMalignant Neoplasm Of PancreasResponseGenetically Engineered MousePancreatic Ductal AdenocarcinomaPharmaceutical PreparationsPathway InteractionsTissuesMutationPre-ClinicalSamplingInnovationComplexProgramsGenetic EngineeringCell LineOlives - DietaryIn VitroMember
Grant awards (39)
Elucidation and targeting of paracrine cascades in PDAC$985,518
U01 · FY2025 · CA · contact PI
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer$582,311
R01 · FY2025 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$405,983
R01 · FY2025 · CA · contact PI
The Bioimaging Core$214,057
P30 · FY2025 · DK · contact PI
Elucidation and targeting of paracrine cascades in PDAC$936,242
U01 · FY2024 · CA · contact PI
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer$552,526
R01 · FY2024 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$485,683
R01 · FY2024 · CA · contact PI
Oncology Precision Therapeutics and Imaging Core$258,639
P30 · FY2024 · CA · contact PI
The Bioimaging Core$216,525
P30 · FY2024 · DK · contact PI
Elucidation and targeting of paracrine cascades in PDAC$985,518
U01 · FY2023 · CA · contact PI
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer$564,115
R01 · FY2023 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$397,862
R01 · FY2023 · CA · contact PI
Oncology Precision Therapeutics and Imaging Core$258,639
P30 · FY2023 · CA · contact PI
The Bioimaging Core$216,525
P30 · FY2023 · DK · contact PI
Elucidation and targeting of paracrine cascades in PDAC$985,518
U01 · FY2022 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$409,428
R01 · FY2022 · CA · contact PI
Oncology Precision Therapeutics and Imaging Core$258,639
P30 · FY2022 · CA · contact PI
The Bioimaging Core$215,867
P30 · FY2022 · DK · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$385,147
R01 · FY2021 · CA · contact PI
Oncology Precision Therapeutics and Imaging Core$258,639
P30 · FY2021 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$385,147
R01 · FY2020 · CA · contact PI
Oncology Precision Therapeutics and Imaging Core$258,639
P30 · FY2020 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$371,711
R01 · FY2019 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$395,064
R01 · FY2018 · CA · contact PI
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer$404,558
R01 · FY2017 · CA · contact PI
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer$334,075
R01 · FY2015 · CA · contact PI
Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer$172,340
R21 · FY2015 · CA · contact PI
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer$385,747
R01 · FY2014 · CA · contact PI
Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer$206,431
R21 · FY2014 · CA · contact PI
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer$314,031
R01 · FY2013 · CA · contact PI
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer$334,075
R01 · FY2012 · CA · contact PI
Micro Ultrasound Scanner to Track Tumor Models$393,698
S10 · FY2011 · RR · contact PI
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer$334,075
R01 · FY2011 · CA · contact PI
Pre-Clinical Evaluation of Novel Therapeutics for PDA$43,428
F32 · FY2008 · CA · contact PI
Pre-Clinical Evaluation of Novel Therapeutics for PDA$7,000
F32 · FY2008 · CA · contact PI
Pre-Clinical Evaluation of Novel Therapeutics for PDA$41,796
F32 · FY2007 · CA · contact PI
Pre-Clinical Evaluation of Novel Therapeutics for PDA$7,000
F32 · FY2007 · CA · contact PI
Pre-Clinical Evaluation of Novel Therapeutics for PDA$38,976
F32 · FY2006 · CA · contact PI
Pre-Clinical Evaluation of Novel Therapeutics for PDA$7,000
F32 · FY2006 · CA · contact PI